Cello Health PLC using EPIC/TICKER code (LON:CLL) had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘HOLD’ today by analysts at Liberum Capital. Cello Health PLC are listed in the Consumer Services sector within AIM. Liberum Capital have set a target price of 135 GBX on its stock. This would imply the analyst believes there is now a potential upside of 6.3% from the opening price of 126.95 GBX. Over the last 30 and 90 trading days the company share price has increased 2.95 points and increased 12.95 points respectively. The 1 year high for the share price is 140 GBX while the 52 week low for the stock is 95 GBX.
Cello Health PLC has a 50 day moving average of 126.84 GBX and a 200 Day Moving Average share price is recorded at 123.35. There are currently 106,088,917 shares in issue with the average daily volume traded being 71,550. Market capitalisation for LON:CLL is £134,679,728 GBP.
